n-acetylgalactosamine 4-sulfatase
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Sep 1, 2000 (NCT00048620)
Timeline
Indications
Studied for
Mechanism of action
- UDP-glucose 4-epimeraseSupplementation
GALE supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- n-acetylgalactosamine 4-sulfatase
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00104234 | Phase 3 | Feb 1, 2004 | Biomarin |
| NCT00067470 | Phase 3 | Sep 1, 2003 | Biomarin |
| NCT00048711 | Phase 2 | Mar 1, 2002 | Biomarin |
| NCT00048620 | Phase 1 | Sep 1, 2000 | Biomarin |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biomarin | For profit | 4 | 4 | 3 | 2000 |
1 organizations
Page 1 / 1